M&A Deal Summary

Crescita Therapeutics Acquires Occy

On June 20, 2024, Crescita Therapeutics acquired consumer products company Occy

Acquisition Highlights
  • This is Crescita Therapeutics’ 2nd transaction in the Consumer Products sector.
  • This is Crescita Therapeutics’ 2nd transaction in Canada.
  • This is Crescita Therapeutics’ 2nd transaction in Quebec.

M&A Deal Summary

Date 2024-06-20
Target Occy
Sector Consumer Products
Buyer(s) Crescita Therapeutics
Deal Type Special Situations/Distressed

Target

Occy

Laval, Quebec, Canada
Occy is a manufacturer and distributor of high-quality dermo-cosmetic products. Occy is based in Laval, Quebec.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Crescita Therapeutics

Laval, Quebec, Canada

Category Company
Founded 2016
Sector Life Science
Employees62
Revenue 18M CAD (2023)
DESCRIPTION

Crescita Therapeutics is a drug development company that owns topical products for treating medical conditions in dermatology and pain. Crescita Therapeutics was founded in 2016 and is based in Laval, Canada.


DEAL STATS #
Overall 2 of 2
Sector (Consumer Products) 2 of 2
Type (Special Situations/Distressed) 1 of 1
State (Quebec) 2 of 2
Country (Canada) 2 of 2
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-09-01 INTEGA Skin Sciences

Montreal, Quebec, Canada

INTEGA Skin Sciences, Inc. is a dermatology company which develops, manufactures, sells and markets science-based quality skin care products.

Buy $8M